Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MethylGene Inc MYLGF

Healthcare Biotechnology

Bullboard (GREY:MYLGF)

View:
1 2 3 4 5 6 7 8 9 10 Next
Post by Jimmyplanton Aug 15, 2013 6:00pm

Piper Jaffray Starts Mirati Therapeutics (MRTX) at Overweight

Piper Jaffray initiates coverage on Mirati Therapeutics (NASDAQ:MRTX) with a Overweight. PT $22.00.
239
Post by Jimmyplanton Jul 24, 2013 1:02am

Mirati Therapeutics: Revamped And Ready To Go With A Targeted Oncology Pipeline

https://seekingalpha.com/article/1562922-mirati-therapeutics-revamped-and-ready-to-go-with-a-targeted-oncology-pipeline
281
Comment by gmarc66on Apr 25, 2013 12:11pm

RE: New low..tiime for a boucne after big % drop

Looking good, cheapies were had, bounce looks good for more as buyers keep showing up to pick up any sells...any half decent news will make it run..glta
176
Discussion
Post by gmarc66on Apr 24, 2013 2:47pm

New low..tiime for a boucne after big % drop

Get them cheap for a bounce play..glta
199
Post by gmarc66on Apr 24, 2013 2:47pm

New low..tiime for a boucne after big % drop

Get them cheap for a bounce play..glta
266
Post by cousinwoolieon Mar 26, 2012 9:26pm

Looks like a bad year

Glad I never bought
257
Post by noGnoG8on Sep 10, 2011 3:42pm

MGCD0103.

Cytotherapy. 2011 May;13(5):618-28. Epub 2010 Dec 20.Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the ...more  
245
Post by noGnoG8on Sep 10, 2011 3:35pm

they don,t talk about this drug anymore

Expert Opin Investig Drugs. 2011 Jun;20(6):823-9. Epub 2011 May 10.Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor.Boumber Y, Younes A, Garcia-Manero G. Source ...more  
263
Post by noGnoG8on Sep 10, 2011 3:32pm

celgene

Cancer Sci. 2011 Jun;102(6):1201-7. doi: 10.1111/j.1349-7006.2011.01921.x. Epub 2011 Apr 18.Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells.Sung V, Richard ...more  
243
Post by Sherrilynneon Jun 24, 2011 11:19am

The little Company that Could?

THE RECENT DRUG TRAILS HAVE BEEN MOSTLY POSITIVE, IT WOULD BE FANTASTIC TO HAVE A CURE FOR CANCER TUMORS OR EVEN SOME REAL RELIEF FOR THE CANCER PATIENTS.  IE-PAIN RELIEF OR SLOW THE TUMOR ...more  
354
Post by 2stereoon Apr 13, 2011 8:46pm

Some Info

https://www.andrewtobias.com/bkoldcolumns/110411.htmlData out in early May, maybe I'll hang on.
591
Post by Caly77on Apr 12, 2011 9:57am

copied too early

# Orders Shares Bid Ask Shares # Orders 3 11000 0.510 0.530 8500  ...more  
403
1 2 3 4 5 6 7 8 9 10 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities